Deep search
Search
Images
Copilot
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
8h
Eli Lilly & Co’s Promising Growth: Accelerated Revenue and Drug Pipeline Advances
DBS analyst Nico Chen has maintained their bullish stance on LLY stock, giving a Buy rating on January 21.Invest with Confidence: Follow ...
5h
Eli Lilly & Co: Buy Rating Backed by Promising Orfoglipron Trials and Strong Pharmaceutical Pipeline
In a report released yesterday, Akash Tewari from Jefferies maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Hughes Fire prompts evacs
Trump pardons DC officers
Slander conviction appeal
Defends diversity policies
Re-designates Houthis
Thai same-sex marriage law
NYC aesthetician charged
DOJ halts civil rights work
New panel to probe Jan. 6
Mulls SC governor’s bid
Saudi to invest $600B in US?
San Antonio officers shot
KKK flyers in Kentucky
Curran to lead Secret Service
Houston refinery closure
Workers union reaches deal
Exits Quebec operations
Sues accuser for defamation
'Bling Empire' star dies
ACLU sues over deportations
Picked as ambassador to EU
Former NC judge dies
Loses bid for new trial
Announces return to skiing
CNN announcing layoffs
Weighs police conduct
Legendary guitarist dies
Nashville school shooting
Passes Laken Riley Act
Jobless claims rise slightly
Feedback